Helicobacter pylori in Human Diseases
portes grátis
Helicobacter pylori in Human Diseases
Advances in Microbiology, Infectious Diseases and Public Health Volume 11
Kamiya, Shigeru; Backert, Steffen
Springer Nature Switzerland AG
11/2019
284
Dura
Inglês
9783030219154
Pré-lançamento - envio 15 a 20 dias após a sua edição
pylori is a Gram negative microaerophilic bacterium that can produce various gastric diseases including gastritis, gastroduodenal ulceration, gastric cancer and gastric MALT lymphoma.
1. Genomic diversity of Helicobacter pylori and human migrationsYoshio Yamaoka(Oita University, Japan) E-mail: yyamaoka@oita-u.ac.jp 2. Epidemiology, diagnosis and risk factors of Helicobacter pylori infectionsEliette Touati (Pasteur Institute, France) E-mail: eliette.touati@pasteur.fr 3. Activities and functional importance of Helicobacter pylori virulence factorsDionyssios Sgouras (Pasteur Institute, France) E-mail: dionsgouras@gmail.com 4. Structural and functional aspects of the Helicobacter pylori proteomeGiuseppe Zanotti (University of Padova, Italy) E-mail: giuseppe.zanotti@unipd.it 5. Role of adhesion to epithelial cells in gastric colonization by H. pylori Eric Sundberg (University of Maryland, USA) E-mail: esundberg@ihv.umaryland.edu 6. Interplay of Helicobacter pylori with immune cells: impact on gastric pathologySteffen Backert (Friedrich-Alexander University Erlangen, Germany) E-mail: Ebook-Helicobacter@gmx.de 7. Helicobacter pylori infection of childrenMasumi Okuda (Aichi Medical University, Japan) E-mail: okuda@naxnet.or.jp 8. Non-malignant Helicobacter pylori-associated diseasesMichael Vieth (Institute of Pathology, Germany) E-mail: vieth.lkpathol@uni-bayreuth.de 9. Malignant Helicobacter pylori-associated diseases: gastric cancer and MALT lymphomaMasanori Hatakeyama (The University of Tokyo, Japan) E-mail: mhata@m.u-tokyo.ac.jp 10. Host genetic polymorphisms in gastric disease outcomeMargeruite Clyne (University College Dublin, Ireland) E-mail: marguerite.clyne@ucd.ie 11. Helicobacter pylori genetic polymorphisms in gastric disease developmentScott Merrell (Uniformed Services University of the Health Sciences, USA) E-mail: douglas.merrell@usuhs.edu 12. Crosstalk of Helicobacter pylori with the gastrointestinal microbiotaCeu Figueiredo (University of Porto, Portugal) E-mail: cfigueiredo@ipatimup.pt 13. Treatment of Helicobacter pylori infectionAkiko Shiotani (Kawasaki Medical University, Japan) E-mail: shiotani@med.kawasaki-m.ac.jp 14. Role of probiotics in eradication therapy for Helicobacter pylori infectionShigeru Kamiya (Kyorin University, Japan) E-mail: skamiya@ks.kyorin-u.ac.jp 15. Immunity and vaccine development against Helicobacter pyloriAnna Walduck (RMIT University, Australia) E-mail: anna.walduck@rmit.edu.au
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
pylori is a Gram negative microaerophilic bacterium that can produce various gastric diseases including gastritis, gastroduodenal ulceration, gastric cancer and gastric MALT lymphoma.
1. Genomic diversity of Helicobacter pylori and human migrationsYoshio Yamaoka(Oita University, Japan) E-mail: yyamaoka@oita-u.ac.jp 2. Epidemiology, diagnosis and risk factors of Helicobacter pylori infectionsEliette Touati (Pasteur Institute, France) E-mail: eliette.touati@pasteur.fr 3. Activities and functional importance of Helicobacter pylori virulence factorsDionyssios Sgouras (Pasteur Institute, France) E-mail: dionsgouras@gmail.com 4. Structural and functional aspects of the Helicobacter pylori proteomeGiuseppe Zanotti (University of Padova, Italy) E-mail: giuseppe.zanotti@unipd.it 5. Role of adhesion to epithelial cells in gastric colonization by H. pylori Eric Sundberg (University of Maryland, USA) E-mail: esundberg@ihv.umaryland.edu 6. Interplay of Helicobacter pylori with immune cells: impact on gastric pathologySteffen Backert (Friedrich-Alexander University Erlangen, Germany) E-mail: Ebook-Helicobacter@gmx.de 7. Helicobacter pylori infection of childrenMasumi Okuda (Aichi Medical University, Japan) E-mail: okuda@naxnet.or.jp 8. Non-malignant Helicobacter pylori-associated diseasesMichael Vieth (Institute of Pathology, Germany) E-mail: vieth.lkpathol@uni-bayreuth.de 9. Malignant Helicobacter pylori-associated diseases: gastric cancer and MALT lymphomaMasanori Hatakeyama (The University of Tokyo, Japan) E-mail: mhata@m.u-tokyo.ac.jp 10. Host genetic polymorphisms in gastric disease outcomeMargeruite Clyne (University College Dublin, Ireland) E-mail: marguerite.clyne@ucd.ie 11. Helicobacter pylori genetic polymorphisms in gastric disease developmentScott Merrell (Uniformed Services University of the Health Sciences, USA) E-mail: douglas.merrell@usuhs.edu 12. Crosstalk of Helicobacter pylori with the gastrointestinal microbiotaCeu Figueiredo (University of Porto, Portugal) E-mail: cfigueiredo@ipatimup.pt 13. Treatment of Helicobacter pylori infectionAkiko Shiotani (Kawasaki Medical University, Japan) E-mail: shiotani@med.kawasaki-m.ac.jp 14. Role of probiotics in eradication therapy for Helicobacter pylori infectionShigeru Kamiya (Kyorin University, Japan) E-mail: skamiya@ks.kyorin-u.ac.jp 15. Immunity and vaccine development against Helicobacter pyloriAnna Walduck (RMIT University, Australia) E-mail: anna.walduck@rmit.edu.au
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
